Metraipolis › archive › dc_a8095683b1be

Safety and antibody responses to inactivated COVID-19 vaccines among elderly patients with COPD: a prospective cohort study — Europe PMC PMID:42367765

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42367765
DOI
10.3389/fimmu.2026.1840305
License (as archived)
solo-consultazione
Archived
2026-10-31T13:47:01.387Z
SHA-256 of the archived text
cea3823c147fd1a8d0327e2837608cd92c9d0986e0f887e75a798be185480ae8
Stable URL of this page
https://metraipolis.com/documento/dc_a8095683b1be

How to cite

Safety and antibody responses to inactivated COVID-19 vaccines among elderly patients with COPD: a prospective cohort study — Europe PMC PMID:42367765 — Europe PMC (en), https://europepmc.org/article/MED/42367765 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a8095683b1be (Metraipolis archive dc_a8095683b1be, sha256 cea3823c147fd1a8d0327e2837608cd92c9d0986e0f887e75a798be185480ae8)
BibTeX
@misc{dca8095683b1be,
  title = {Safety and antibody responses to inactivated COVID-19 vaccines among elderly patients with COPD: a prospective cohort study — Europe PMC PMID:42367765},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42367765},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a8095683b1be; sha256 cea3823c147fd1a8d0327e2837608cd92c9d0986e0f887e75a798be185480ae8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42367765. Agents can read the archived copy with the MCP tool read_document.